Lataa...
Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
Rapid vaccine development in response to an outbreak of a new emerging infectious disease (EID) is a goal targeted by public health agencies worldwide. This goal becomes more complicated when there are no standardized sets of viral and immunological assays, no accepted and well-characterized samples...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816404/ https://ncbi.nlm.nih.gov/pubmed/31268394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1634992 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|